Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Advancements in Case Studies

Autoimmune Hemolytic Anemia Induced by Anti-D Injection

  • Open or CloseMariana Boulos1,2, Elias Saad1,2 and Nimer Assy1,2*

    1Internal medicine Department A , Galilee medical Center, Nahariya 221001, Israel

    2The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, 1311502, Israel

    *Corresponding author:Nimer Assy, Internal medicine Department A , Galilee medical Center, Nahariya 221001 and The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, 1311502, Israel

Submission:January 03, 2023; Published: January 09, 2023

DOI: 10.31031/AICS.2023.03.000570

ISSN 2639-0531
Volume3 Issue4

Abstract

Anti-D immunoglobulin can cause acute hemolysis when used in the treatment of Rh(D) positive patients with immune thrombocytopenic purpura (ITP). The use of Anti-D immunoglobulin to prevent Rh(D) alloimmunization during pregnancy is quite safe. Although drug induced immune hemolytic anemia have been described during pregnancy, hemolytic anemia was not described as adverse event of Anti-D immunoglobulin administered as a prophylaxis for Rh(D) negative pregnant women. Herein we present an unusual case of warm type autoimmune hemolytic anemia induced by Anti-D immunoglobulin in O Rho(D) negative pregnant women.

Keywords:AIHA (Autoimmune hemolytic anemia); Anti-D; Pregnancy

Get access to the full text of this article